Table 4.
Morbidity and mortality
| OG (48) | LG (27) | P value | |
|---|---|---|---|
| Complications severitya | |||
| None | 39 (81.3%) | 23 (85.2%) | 0.464 |
| Grade I | 1 (2.1%) | 2 (7.4%) | |
| Grade II | 7 (14.6%) | 2 (7.4%) | |
| Grade V | 1 (2.1%) | 0 (0.0%) | |
| Morbidity | |||
| None | 39 | 23 | 0.514 |
| Pneumonia | 1 | 1 | |
| Wound | 1 | 2 | |
| Leakage | 1 | 0 | |
| Bleeding | 4 | 0 | |
| Others | 2 | 1 | |
| Transfusion | |||
| RBC | 3 | 0 | 0.549 |
| FFP | 1 | 0 | 1.000 |
| In-hospital mortality | 1 | 0 | 1.000 |
OG open gastrectomy group, LG laparoscopic or laparoscopic-assisted gastrectomy group
aThe Clavien-Dindo classification of surgical complications. Grade I: any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic or radiological interventions. Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgesics, diuretics and electrolytes and physiotherapy, including wound infections opened at the bedside. Grade II: requiring pharmacological treatment with drugs other than those allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included. Grade IIIa: requiring surgical, endoscopic or radiological intervention not under general anesthesia; grade IIIb: an intervention under general anesthesia. Grade IVa: a life-threatening complication (including CNS complications) + requiring IC/ICU management with single-organ dysfunction (including dialysis); grade IVb: multiorgan failure. Grade V: death of the patient